Application of Different Cell Therapies in the Treatment of Covid-19

Authors

  • Yunzi Li

DOI:

https://doi.org/10.54097/bh40vd62

Keywords:

Covid-19; traditional therapies; cell therapy.

Abstract

Covid-19, which erupted in Wuhan, China, in 2019, was highly contagious and caused panic. covid-19 has a sequelae, and the World Health Organization reports that about 10 to 20 percent of crown infections have new crown sequels, including exhaustion, overheart movement, shortness of breath, cognitive difficulties, chronic pain, sensory function, muscle weakness, etc. Research institutions such as the United States, the United Kingdom, the Netherlands and other research institutions have released a considerable number of new crown sequels in their own country, and some of the population is already unable to work. There are still no systematic treatment, only some of the symptoms proposed based on the symptoms, these traditional therapies do not treat the sequelae, so some new therapies have been proposed. This paper will revolve around cell therapy. The common methods used in clinical treatment of diseases are surgery, chemical drugs, ion exposure, plant drugs. The development of modern medical theory and technology gradually introduced cell therapy into the clinic. Cell therapy is a treatment with functional cells as the main body. Cell therapy can be used as an independent treatment or combined with the above-mentioned routine treatment. In recent years, cell therapy has shown increasing application value in the treatment of genetic diseases, cancer, tissue injury, diabetes and other diseases, and details current cell therapy and prospects.

Downloads

Download data is not yet available.

References

Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology, 2016, 3(1): 237–261.

Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature, 2022, 604.

Becker J H, Lin J J, Doernberg M, et al. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Network Open, 2021, 4(10): e2130645.

Petty A J, Yang Y. Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies. Cells, 2019, 8(12): 1526.

Gentile P, Sterodimas A, Pizzicannella J, et al. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease. Aging and disease, 2020, 11(5): 1191.

Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 2008, 8(9): 726–736.

Smith D M, Schafer J, Tullius B P, et al. Natural killer cells for antiviral therapy. Science Translational Medicine, American Association for the Advancement of Science, 2023, 15(677): eabl5278.

Ahmed S F, Quadeer A A, McKay M R. SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron. Viruses, 2022, 14(1): 79.

Tai W, Feng S, Chai B, et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nature Communications, Nature Portfolio, 2023, 14: 2962.

Nobari S, Rezvan M, Dashtestani F, et al. Cellular Therapy: The Hope for Covid-19. Avicenna Journal of Medical Biotechnology, 2022, 14(2): 104–113.

Downloads

Published

29-12-2023

How to Cite

Li, Y. (2023). Application of Different Cell Therapies in the Treatment of Covid-19. Highlights in Science, Engineering and Technology, 74, 526-532. https://doi.org/10.54097/bh40vd62